Healthcare has become increasingly patient-centric. Simultaneously, patients are far more likely to use digital devices to access information about their conditions than ever before. The biopharma industry has taken notice and has become highly interested in digital companions as a means of engaging patients in their treatment journeys and elevating their overall experience. This paper:
- Defines “digital companion”
- Explores the value of digital companions from the biopharma company and patient perspectives
- Outlines a strategic process that biopharma companies can use for understanding patient needs and initiating the process of fielding a successful digital companion
